Search
OSR Holdings Inc
OSRHAdd to Watchlist
0.321USD
+0.011+3.42%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
10.68MMarket Cap
11.54P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+3.42%
5 Days
-4.01%
1 Month
-22.93%
6 Months
-45.61%
Year to Date
-43.17%
1 Year
-76.25%
Key Figures
0.311Open
0.327High
1.32MVolume
11.54P/E TTM
--P/E Dynamic
--Dividend TTM
3.98%Turnover Ratio
0.310Prev. Close
0.302Low
274.93KTurnover
LossP/E Static
0.10P/B
0.00%Div Yield TTM
-11.04%ROA
3.30052wk High
3.57Volume Ratio
-2.41MNet Profit
33.30MShares
0.0278EPS TTM
--Beta
-10.63%ROE
0.38052wk Low
8.03%Amplitude
33.11%Gross Margin
10.68MMarket Cap
-3.45Reward/Risk
7.39%Risk Rate
TradingKey Stock Score of OSR Holdings Inc
Currency: USD Updated: 2026-07-02Key Insights
OSR Holdings Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 200 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OSR Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
OSR Holdings Inc Highlights
StrengthsRisks
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company’s subsidiary, Vaximm’s flagship asset, VXM01, is a late clinical-stage (NCT037500701) immuno-oncology candidate for glioblastoma. Vaximm has three clinical and pre-clinical drug candidates targeting diseases ranging from glioblastoma to gastrointestinal stromal tumor to ocular diseases. The Company has operations in Europe and South Korea.
Growing
The company is in a growing phase, with the latest annual income totaling USD 2.91M.
Overvalued
The company’s latest PE is 11.54, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 220.68K shares, decreasing 93.19% quarter-over-quarter.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
10.000
Target Price
+3125.81%
Upside Space
OSR Holdings Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
OSR Holdings Inc Info
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company’s subsidiary, Vaximm’s flagship asset, VXM01, is a late clinical-stage (NCT037500701) immuno-oncology candidate for glioblastoma. Vaximm has three clinical and pre-clinical drug candidates targeting diseases ranging from glioblastoma to gastrointestinal stromal tumor to ocular diseases. The Company has operations in Europe and South Korea.
Ticker SymbolOSRH
CompanyOSR Holdings Inc
CEOHwang (Kuk Hyoun)
Websitehttps://osr-holdings.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of OSR Holdings Inc (OSRH)?
The current price of OSR Holdings Inc (OSRH) is 0.32.
What is the symbol of OSR Holdings Inc?
The ticker symbol of OSR Holdings Inc is OSRH.
What is the 52-week high of OSR Holdings Inc?
The 52-week high of OSR Holdings Inc is 3.30.
What is the 52-week low of OSR Holdings Inc?
The 52-week low of OSR Holdings Inc is 0.38.
What is the market capitalization of OSR Holdings Inc?
The market capitalization of OSR Holdings Inc is 10.68M.
Is OSR Holdings Inc (OSRH) currently rated as Buy, Hold, or Sell?
According to analysts, OSR Holdings Inc (OSRH) has an overall rating of Buy, with a price target of 10.00.
What is the Earnings Per Share (EPS TTM) of OSR Holdings Inc (OSRH)?
The Earnings Per Share (EPS TTM) of OSR Holdings Inc (OSRH) is -0.92.